NASS 2019 Annual Meeting

Abstract Presentations: Biomechanics and Basic Science II (Room Room W470a)

Moderator: Dominic W. Pelle, MD

 

135. Neutral cervical sagittal vertical axis (SVA) varies with T1 Tilt
Ryan Hofler, MD, MS1; Muturi Muriuki, PhD2; Robert M. Havey, MS3; Kenneth R. Blank, MS, MHA4; Avinash G. Patwardhan, PhD5; G. Alexander Jones, MD1
1Loyola University Medical Center, Maywood, IL, US; 2Forest Park, IL, US; 3Edward Hines Jr. VA Hospital, Hines, IL, US; 4Tinley Park, IL, US; 5Loyola University Medical Center Dept. of Orthopaedic Surgery, Maywood, IL, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

136. Biomechanical study of the sacral replacement part as a model for spinopelvic reconstruction following total sacrectomy
Antonio Martin Benlloch, MD, PhD1; Ana Maria Morales-Codina, PhD2
1Hospital Universitario, Valencia, Valencia, Spain; 2University Doctor Peset Aleixandre Hospital, Valencia, Spain

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

137. Surgical overcorrection relative to ideal spinopelvic alignment reduces rates of pelvic non-response for severely mal-aligned adult spinal deformity patients
Peter G. Passias, MD1; Cole Bortz, BA2; Haddy Alas, BS3; Avery Brown, BS3; Katherine E. Pierce, BS2; Christopher Varlotta, BS3; Jordan H. Manning, BA3; Ethan W. Ayres, MPH3; Edem J. Abotsi, BA3; Erik Wang, BA3; Dainn Woo, BS3; Dennis Vasquez-Montes, MS, BA3; Mohamed A. Moawad, MPH3; Constance Maglaras, PhD2; Bassel G. Diebo, MD4; Tina Raman, MD2; Themistocles S. Protopsaltis, MD3; Aaron J. Buckland, MBBS, FRACS3; Michael C. Gerling, MD5; Frank J. Schwab, MD6; Renaud Lafage, MSc6; Virginie Lafage, PhD6
1NY Spine Institute, NYU Langone Health, New York, NY, US; 2New York, NY, US; 3Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, NY, US; 4Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, NY, US; 5NYU Langone, Brooklyn, Brooklyn, NY, US; 6Hospital for Special Surgery, New York, NY, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

138. Can dual headed pedicle screws simplify use of dual rods and without sacrificing biomechanical stability?
Jakub Godzik, MD1; Bernardo De Andrada Pereira, MD1; Anna G. Newcomb, MS2; Brian Kelly, PhD3; Jay D. Turner, MD, PhD4
1Phoenix, AZ, US; 2St. Joseph's Hospital and Medical Center, Phoenix, AZ, US; 3Barrow Neurological Institute, Phoenix, AZ, US; 4Barrow Brain and Spine, Phoenix, AZ, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

139. Serum MicroRNA miR-155-5p as a potential biomarker of degenerative disc disease in patients with low back pain
Srikanth Divi, MD; Dessislava Markova, PhD1; Ryan Guzek, BS1; Taolin Fang, MD, PhD2; Alan S. Hilibrand, MD3; Jeffrey A. Rihn, MD4; Alexander R. Vaccaro, MD, PhD3; D. Greg Anderson, MD3; Gregory D. Schroeder, MD2; Christopher K. Kepler, MD, MBA5
1Thomas Jefferson University, Philadelphia, PA, US; 2Rothman Institute, Thomas Jefferson University, Philadelphia, PA, US; 3Rothman Institute, Philadelphia, PA, US; 4Thomas Jefferson University Hospital, The Rothman Institute, Philadelphia, PA, US; 5Philadelphia, PA, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

140. Rapid reversal of surgical steps minimizes spinal cord injury in a porcine model
Vishal Sarwahi, MD1; Jesse M. Galina, BS2; Aaron  M. Atlas, BS3; Sayyida S. Hasan, BS3; Terry D. Amaral, MD4
1North Shore LIJ Health System, New Hyde Park, NY, US; 2New Hyde Path, US; 3Cohen Children's Medical Center, New Hyde Park, NY, US; 4Northwell Health, Lake Success, NY, US>

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

141. Autophagy induction contributes to the neuroprotective effect of intermittent fasting in experimental spinal cord injury
Wei Yuan, MD, PhD; Yue Zhu, MD, PhD
First Hospital of China Medical University, Shenyang, China

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

Discussion